Your browser doesn't support javascript.
loading
Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection.
Sander, Melissa S; Laah, Sylvain N; Titahong, Collins N; Lele, Christian; Kinge, Thompson; de Jong, Bouke C; Abena, Jean-Louis F; Codlin, Andrew J; Creswell, Jacob.
Afiliação
  • Sander MS; Tuberculosis Reference Laboratory Bamenda, PO Box 586, Bamenda, Cameroon.
  • Laah SN; Bamenda Regional Hospital, Bamenda, PO Box, Cameroon.
  • Titahong CN; Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium.
  • Lele C; Bamenda Regional Hospital, Bamenda, PO Box, Cameroon.
  • Kinge T; Bamenda Regional Hospital, Bamenda, PO Box, Cameroon.
  • de Jong BC; Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium.
  • Abena JF; National TB Control Program, BP 15656 Yaounde, Cameroon.
  • Codlin AJ; Stop TB Partnership, Chemin du Pommier 40, 1218 Le Grand-Saconnex, Geneva, Switzerland.
  • Creswell J; Stop TB Partnership, Chemin du Pommier 40, 1218 Le Grand-Saconnex, Geneva, Switzerland.
J Clin Tuberc Other Mycobact Dis ; 15: 100095, 2019 May.
Article em En | MEDLINE | ID: mdl-31720422
BACKGROUND: Better screening and testing approaches are needed to improve TB case finding, particularly in health facilities where many people with TB seek care but are not diagnosed using the existing approaches. OBJECTIVE: We aimed to evaluate the performance of various TB screening and testing approaches among hospital outpatients in a setting with a high prevalence of HIV/TB. METHODS: We screened outpatients at a large hospital in Cameroon using both chest X-ray and a symptom questionnaire including current cough, fever, night sweats and/or weight loss. Participants with a positive screen were tested for TB using smear microscopy, the Xpert MTB/RIF assay, and culture. RESULTS: Among 2051 people screened, 1137 (55%) reported one or more TB symptom and 389 (19%) had an abnormal chest X-ray. In total, 1255 people (61%) had a positive screen and 31 of those screened (1.5%) had bacteriologically confirmed TB. To detect TB, screening with cough >2 weeks had a sensitivity of 61% (95% CI, 44-78%). Screening for a combination of cough >2 -weeks and/or abnormal chest X-ray had a sensitivity of 81% (95% CI, 67-95%) and specificity of 71% (95% CI, 69-73%), while screening for a combination of cough >2 weeks or any of 2 or more symptoms had a similar performance. Smear microscopy and Xpert MTB/RIF detected 32% (10/31) and 55% (17/31), respectively, of people who had bacteriologically-confirmed TB. CONCLUSIONS: Screening hospital outpatients for cough >2 weeks or for at least 2 of current cough, fever, night sweats or weight loss is a feasible strategy that had a high relative yield to detect bacteriologically-confirmed TB in this population. Clinical diagnosis of TB is still an important need, even where Xpert MTB/RIF testing is available.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Clin Tuberc Other Mycobact Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Camarões País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Clin Tuberc Other Mycobact Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Camarões País de publicação: Reino Unido